Takeda Pharmaceutical calls 1.125% senior notes due 2022 at par

By Marisa Wong

Los Angeles, July 12 – Takeda Pharmaceutical Co., Ltd. will redeem its €1.5 billion outstanding 1.125% senior notes due 2022 (ISINs: XS1843449635, XS1843449049) in full on Aug. 10, according to a company notice.

The notes are being redeemed at the greater of (a) par or (b) the sum of the present values of the principal and remaining interest payments through the par call date, discounted to the redemption date at the applicable government bond rate plus 25 basis points. Interest will also be paid.

MUFG Bank, Ltd. is the paying agent.

The pharmaceutical company is based in Osaka, Japan.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.